Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2022-04-11 Major Shareholding Noti…
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of a major shareholder (Kang Il-mo) in KM Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2022-04-11 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from a General Meeting of Shareholders (Annual General Meeting). It details the outcomes of agenda items such as financial statement approval, dividend decisions, director appointments, and amendments to business purposes. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2022-03-28 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by KM Pharmaceutical Co., Ltd. It explicitly lists corrections made to specific sections of the previously filed Annual Report, such as 'Company Overview', 'Business Content', and 'Management's Discussion and Analysis'. Since this document is a formal regulatory filing that amends a previously submitted Annual Report and contains substantive financial and operational data corrections, it is classified as an Annual Report (10-K) filing type, as it serves as an official update to the company's yearly performance documentation. FY 2021
2022-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from KM Pharmaceutical. It provides a summary of the audit opinion (unqualified/proper) and key financial data (assets, liabilities, revenue, profit/loss) for the fiscal year. While it contains financial data, it is a short regulatory disclosure announcing the receipt and submission of the audit report to the exchange, rather than the full, multi-page audited financial statement document itself. Therefore, it fits the definition of a Report Publication Announcement (RPA). FY 2021
2022-03-18 Korean
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2021 (2021.01.01-2021.12.31) submitted to the Financial Supervisory Service and Korea Exchange. It contains comprehensive company information, including business overview, history, capital changes, and management details. This is the standard Korean regulatory filing equivalent to a 10-K annual report. FY 2021
2022-03-18 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for KM Pharmaceutical. It details the date, location, agenda items (such as financial statement approval, director appointments, and articles of incorporation changes), and board resolution details. This document is a standard proxy solicitation/notice of meeting provided to shareholders to inform them of the upcoming AGM and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2022-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.